Health Outcomes Research in Medicine
Volume 1, Issue 2 , Pages e111-e122, December 2010

Development and Analysis of Item Response Theory-based Short-form Depression Severity Scales Based on the HDRS and MADRS

  • Dennis A. Revicki, PhD

      Affiliations

    • Center for Health Outcomes Research, United BioSource Corporation, Bethesda, Maryland
    • Corresponding Author InformationCorresponding Author: Dennis A. Revicki, PhD, Center for Health Outcomes Research, United Biosource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814.
  • ,
  • Wen-Hung Chen, PhD

      Affiliations

    • Center for Health Outcomes Research, United BioSource Corporation, Bethesda, Maryland
  • ,
  • Lori Frank, PhD

      Affiliations

    • Center for Health Outcomes Research, United BioSource Corporation, Bethesda, Maryland
  • ,
  • Douglas Feltner, MD

      Affiliations

    • Pfizer, Inc., Ann Arbor, Michigan
  • ,
  • Robert Morlock, PhD

      Affiliations

    • Pfizer, Inc., Ann Arbor, Michigan

published online 17 May 2010.

Abstract 

Objectives

The Hamilton Depression Rating Scale (HDRS) is the most frequently used primary endpoint for antidepressant clinical trials. This study developed and evaluated the psychometric characteristics of 3 item response theory (IRT)-based short-form depression severity scales based on combinations of the HDRS and Montgomery-Asberg Depression Rating Scale (MADRS) items.

Study Design

A secondary analysis was completed using data from 1027 subjects with major depressive disorder participating in 2 antidepressant clinical trials. Data were collected using the HDRS and MADRS throughout the 6-week clinical trials. Maier, Bech, and Gibbons brief depression scales were calculated based on the HDRS.

Results

Three short-form depression severity (DS) scales were developed based on clinician recommendations and IRT analyses, (DS-1, 7 items; DS-2, 8 items; DS-3, 10 items). Internal consistency reliability of the short forms was 0.87 to 0.93. DS were more reliable across the range of the depression than the HDRS or MADRS. The DS scales were correlated 0.27 to 0.29 with HDRS, 0.55 to 0.85 with MADRS, and −0.25 to −0.34 with Quality of Enjoyment and Satisfaction Questionnaire scores at baseline. In 1 clinical trial, none of the depression outcome measures demonstrated statistically significant differences between the paroxetine and placebo groups. In the second clinical trial, there were significant between-group differences in DS-1 (P=.004; ES=0.46), DS-2 (P <.001; ES=0.59), DS-3 (P <.001; ES=0.63), Bech (P=.007; ES=0.43), Maier (P=.009; ES=0.41), Gibbon (P=.003; ES=0.47), HDRS (P=.007; ES=0.43), and MADRS (P=.001; ES=0.54) scores.

Conclusions

The IRT-based short-form depression measures were reliable, valid, and responsive in patients with major depressive disorder. Effect sizes were comparable or better to other depression severity scales.

Keywords: Clinical trials, Depression severity, Hamilton Depression Rating Scale, Item response theory, Major depressive disorder, Montgomery-Asberg Depression Rating Scale, Psychometrics

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by Pfizer Inc., Ann Arbor, Michigan and in part by the National Institutes of Health Patient-Reported Outcomes Measurement Information System contract (1U01AR052177), Bethesda, Maryland.

PII: S1877-1319(10)00004-2

doi:10.1016/j.ehrm.2009.11.001

Health Outcomes Research in Medicine
Volume 1, Issue 2 , Pages e111-e122, December 2010